These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33434738)

  • 1. Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization.
    Pope LG; Manseau MW; Kelley ME; Compton MT
    Schizophr Res; 2021 Feb; 228():83-88. PubMed ID: 33434738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning and cannabis use in first-episode psychosis.
    Karpov B; Lindgren M; Kieseppä T; Wegelius A; Suvisaari J
    Nord J Psychiatry; 2022 Oct; 76(7):551-558. PubMed ID: 34964681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
    Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
    Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.
    Ricci V; Ceci F; Di Carlo F; Lalli A; Ciavoni L; Mosca A; Sepede G; Salone A; Quattrone D; Fraticelli S; Maina G; Martinotti G
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109118. PubMed ID: 34688166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
    Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Schizophr Res; 2014 Sep; 158(1-3):113-9. PubMed ID: 25008791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations of cannabis and methamphetamine use with cognitive performance over the first 2 years of treatment in schizophrenia spectrum disorders.
    Scheffler F; Phahladira L; Hendrikse CB; du Plessis S; Asmal L; Luckhoff HK; Smit AM; Olivier MR; Emsley R
    Early Interv Psychiatry; 2022 Nov; 16(11):1230-1239. PubMed ID: 35108745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reward Learning, Neurocognition, Social Cognition, and Symptomatology in Psychosis.
    Lewandowski KE; Whitton AE; Pizzagalli DA; Norris LA; Ongur D; Hall MH
    Front Psychiatry; 2016; 7():100. PubMed ID: 27378952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of comorbid cannabis use on outcome in first episode psychosis.
    Hadden KL; LeDrew K; Hogan K; Thomas B
    Early Interv Psychiatry; 2018 Oct; 12(5):848-855. PubMed ID: 27592556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial functioning in first-episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Early Interv Psychiatry; 2017 Feb; 11(1):23-36. PubMed ID: 25585960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B
    Allott K; McGorry PD; Yuen HP; Firth J; Proffitt TM; Berger G; Maruff P; O'Regan MK; Papas A; Stephens TCB; O'Donnell CP
    Biol Psychiatry; 2019 Jul; 86(1):35-44. PubMed ID: 30771856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.